A recent study indicates that individuals who stop using new weight-loss injections like Mounjaro or Wegovy can put back on reduced body mass at a significantly accelerated pace than those who halt conventional diet and exercise regimens.
Research printed in a prominent health publication shows that while obese people often shed a large proportion of their total mass while undergoing treatment, the mass comes back at an average rate of 0.8 kg per month once they quit.
"People buying such drugs need to be informed of the potential of rapid rebound weight gain when the medication concludes," cautioned expert Dr. Susan Jebb.
This pace of recovery means a reversion to pre-treatment weight within about 18 months.
Weighing Approaches
The study, which looked at dozens of trials involving thousands of patients, compared the results of these new drugs with other pills.
Scientists emphasize that individuals who shed pounds through dieting usually experience a slower weight regain—around 100 grams monthly—post-intervention.
The Reason for the Fast Rebound
Doctors suggest the way of the injections accounts for the heightened rebound.
These medications mimic a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Sustained high doses of the hormone levels far above than normal may cause the system to produce less of its endogenous GLP-1, and could diminish responsiveness to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this medication leads to hunger is no longer kept in check, making overeating far more likely."
A Chronic Issue?
Health authorities suggest the injections for people with obesity-related health risks, alongside prescribed diet and exercise modifications.
Many experts argue that, considering the significant potential of relapse, the therapy is often ongoing.
This view is supported by drug manufacturers, who note that the results "emphasize the long-term character of obesity," similar to managing conditions like high blood pressure.
User Accounts
Individuals who have stopped the jabs explain a intense resurgence of hunger.
"I experienced something flipping and you become starving," described one woman.
This challenge is compounded if individuals have not developed lasting dietary or behavioural modifications during treatment.
Widespread Interest
Survey data suggest that a significant number of people in the UK have used weight-loss jabs in the past year, with interest remaining high.
- Use is greater among females compared to males.
- The 40s and 50s age group shows the greatest usage rates.
- Many obtain the medications through private prescriptions rather than public health services.
In conclusion, clinicians caution that while these medications are effective agents for shedding pounds, they are not a permanent cure and maintained weight loss relies on ongoing behavioural changes.
